UBS Group’s Sucampo Pharmaceuticals SCMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
– Sell
-100
Closed -$1K – 11082
2014
Q1
$1K Buy
+100
New +$856 ﹤0.01% 10274
2013
Q4
– Sell
-500
Closed -$3K – 11033
2013
Q3
$3K Hold
500
– – ﹤0.01% 9831
2013
Q2
$3K Hold
500
– – ﹤0.01% 9682

Other funds holding SCMP

UBS Group's SCMP Position: Q1 2018 in Review

UBS Group sold out of Sucampo Pharmaceuticals (SCMP) in Q1 2018, closing a stake of 263,403 shares — an estimated $4.73M sold.

UBS Group first reported a position in SCMP in Q2 2014 and held it in 15 quarters. The position peaked at $4.73M in Q4 2017. 2 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • UBS Group reported no remaining Sucampo Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • UBS Group sold 263,403 Sucampo Pharmaceuticals shares in Q1 2018, an estimated $4.73M.
  • UBS Group first reported a position in Sucampo Pharmaceuticals in Q2 2014 and held it in 15 quarters.
  • UBS Group's Sucampo Pharmaceuticals position peaked at $4.73M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals as of Q1 2018.

Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.